Head of Investor Relations
Bio-Rad Laboratories, Inc. (BIO)Equibles does not estimate personal net worth.
Get an email with a short summary when Bio-Rad Laboratories, Inc. publishes a filing, an earnings call transcript or a press release.
Get BIO alertsEdward Chung is recorded as Head of Investor Relations at Bio-Rad Laboratories, Inc. (BIO). Edward Chung has spoken on 13 earnings calls across 1 company, most recently for Bio-Rad Laboratories, Inc. on February 12, 2026. Bio-Rad Laboratories, Inc. is classified in the Medical Devices industry within the Healthcare sector. Other leadership on record at Bio-Rad Laboratories, Inc. includes Norman Schwartz (CEO, CFO and Board Member), Roop K. Lakkaraju (CFO and Chief Accounting Officer), Roop Lakkaraju (CFO) and 7 others.
“Today, we will review the fourth quarter and full year 2025 financial results and provide an update on key business trends for BIO-RAD.”
“Today, we will review the third quarter of 2025 financial results and provide an update on key business trends for BioRad.”
“Today, we will review the second quarter 2025 financial results and provide an update on key business trends for Biorad.”
“Today, we will review the first quarter 2025 financial results and provide an update on key business trends for Biorad.”
“Today, we will review the fourth quarter and full year 2024 financial results and provide an update on key business trends for BioRat. With me on the call today are Norman Schwartz, our Chief John DiVincenzo, President and Chief Operating Officer, and Ruplakaraju, Executive Vice President and Chief Financial Officer.”
Medical Devices · Healthcare
Head of Investor Relations
